Whitehead Biotech Pharmaceutical Co., Ltd. announced its first-quarter financial results for 2026, reporting a basic EPS of TWD -0.08, operating revenue of TWD 35 million, and after-tax net loss of TWD 27 million. These figures reflect the company's financial performance in the biotechnology and medical industry.
Company Code: 4108
Company Name: Whitehead Biotech Pharmaceutical Co., Ltd.
Industry: Biotechnology and medical industry
Fiscal Year/Quarter: 2026 Q1
Basic Earnings Per Share (EPS): TWD -0.08
Operating Revenue: TWD 35 million
Net Profit After Tax: TWD -27 million
FACT BOX
- Source: PR Times
- Category: News